申请人:Kissei Pharmaceutical Co Ltd
公开号:EP0293146A1
公开(公告)日:1988-11-30
Benzofuro[3,2-c]quinoline compounds of the general formula:
wherein R1 represents a hydrogen atom, a hydroxy group or an unsubstituted or substituted straight- or branched-chain alkoxy group having 1 to 10 carbon atoms wherein the substituent is selected from a hydroxy group, a carboxy group, a carbamoyl group and an alkoxycarbonyl group having 2 to 7 carbon atoms; R2 represents a hydrogen atom or an unsubstituted or substituted straight- or branched-chain alkyl group having 1 to 10 carbon atoms wherein the substituent is selected from a hydroxy group, a carboxy group, a carbamoyl group and an alkoxycarbonyl group having 2 to 7 carbon atoms, and the pharmaceutically acceptable salts thereof, possess a strong inhibitory action on bone resorption and a stimulatory effect on ossification and are thus useful for the prevention or treatment of osteoporosis.
苯并呋喃[3,2-c]喹啉化合物的一般式如下:其中R1代表氢原子,羟基或具有1至10个碳原子的未取代或取代的直链或支链烷氧基,其中取代基选自具有2至7个碳原子的羟基,羧基,氨基甲酰基和烷氧羰基基团; R2代表氢原子或具有1至10个碳原子的未取代或取代的直链或支链烷基,其中取代基选自具有2至7个碳原子的羟基,羧基,氨基甲酰基和烷氧羰基基团,以及其药学上可接受的盐,具有强烈的抑制骨吸收和促进骨化作用,因此对于预防或治疗骨质疏松症有用。